Antitumor Activity of the New Bcl-2/Bcl-xl Inhibitor S44563 in Primary Human Uveal Melanoma Xenografts

被引：0
|
作者：
Decaudin, D. [1 ]
Nemati, F. [1 ]
De Montrion, C. [2 ]
Lang, G. [1 ]
Sastre, X. [3 ]
Berthier, L. Kraus [2 ]
Dahmani, A. [1 ]
Desjardins, L. [4 ]
Piperno-Neumann, S. [5 ]
Depil, S. [2 ]
机构：
[1] Inst Curie, Lab Preclin Invest, Paris 05, France
[2] Servier Labs, Suresnes, France
[3] Inst Curie, Dpt Tumor Biol, Paris 05, France
[4] Inst Curie, Dpt Ophthalmol, Paris 05, France
[5] Inst Curie, Dpt Med Oncol, Paris 05, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
777
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [1] Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
    Y Loriot
    P Mordant
    D Dugue
    O Geneste
    A Gombos
    P Opolon
    J Guegan
    J-L Perfettini
    A Pierre
    L K Berthier
    G Kroemer
    J C Soria
    S Depil
    E Deutsch
    Cell Death & Disease, 2014, 5 : e1423 - e1423
  • [2] Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts
    Nemati, Fariba
    de Montrion, Catherine
    Lang, Guillaume
    Kraus-Berthier, Laurence
    Carita, Guillaume
    Sastre-Garau, Xavier
    Berniard, Aurelie
    Vallerand, David
    Geneste, Olivier
    de Plater, Ludmilla
    Pierre, Alain
    Lockhart, Brian
    Desjardins, Laurence
    Piperno-Neumann, Sophie
    Depil, Stephane
    Decaudin, Didier
    PLOS ONE, 2014, 9 (01):
  • [3] Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
    Loriot, Y.
    Mordant, P.
    Dugue, D.
    Geneste, O.
    Gombos, A.
    Opolon, P.
    Guegan, J.
    Perfettini, J-L
    Pierre, A.
    Berthier, L. K.
    Kroemer, G.
    Soria, J. C.
    Depil, S.
    Deutsch, E.
    CELL DEATH & DISEASE, 2014, 5 : e1423 - e1423
  • [4] Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
    Leiter, U
    Schmid, RM
    Kaskel, P
    Peter, RU
    Krähn, G
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2000, 292 (05) : 225 - 232
  • [5] Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
    U. Leiter
    R. M. Schmid
    P. Kaskel
    R. U. Peter
    G. Krähn
    Archives of Dermatological Research, 2000, 292 : 225 - 232
  • [6] A Potent and Highly Efficacious Bcl-2/Bcl-xL Inhibitor
    Aguilar, Angelo
    Zhou, Haibin
    Chen, Jianfang
    Liu, Liu
    Bai, Longchuan
    McEachern, Donna
    Yang, Chao-Yie
    Meagher, Jennifer
    Stuckey, Jeanne
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (07) : 3048 - 3067
  • [7] Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2
    Yoshihito Morimoto
    Kimihiko Takada
    Osamu Takeuchi
    Kazuhiro Watanabe
    Masayoshi Hirohara
    Tomoyuki Hamamoto
    Yutaka Masuda
    Molecular and Cellular Biochemistry, 2020, 472 : 187 - 198
  • [8] Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2
    Morimoto, Yoshihito
    Takada, Kimihiko
    Takeuchi, Osamu
    Watanabe, Kazuhiro
    Hirohara, Masayoshi
    Hamamoto, Tomoyuki
    Masuda, Yutaka
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2020, 472 (1-2) : 187 - 198
  • [9] Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
    Mena, Salvador
    Rodriguez, Maria L.
    Ortega, Angel
    Priego, Sonia
    Obrador, Elena
    Asensi, Miguel
    Petschen, Ignacio
    Cerda, Miguel
    Brown, Bob D.
    Estrela, Jose M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [10] Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
    Salvador Mena
    María L Rodriguez
    Angel Ortega
    Sonia Priego
    Elena Obrador
    Miguel Asensi
    Ignacio Petschen
    Miguel Cerdá
    Bob D Brown
    José M Estrela
    Journal of Translational Medicine, 10
12345